Bad dilution, circa 250M shares on issue post raise, assuming the 30c options will also be executed. $500M takeover required to match Sumi's $2 offer from 2019.
The good to come of this CR:
1. When this cash runs out, we will have clinical trial results from DFU, GvHD and Renal trials.
2. Maybe the gag on brokers by SI is over?
Ann: Trading Halt, page-8
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.01M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 24.5¢ | 24.5¢ | $3.093K | 12.62K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9940 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 301 | 1 |
View Market Depth
| Last trade - 11.05am 24/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |